📊 CCRN Key Takeaways
Investment Thesis
Cross Country Healthcare faces severe operational distress with massive revenue contraction of 21.6% YoY and deteriorating profitability, including a net loss of $94.9M and negative operating income of $84.4M. While the company maintains adequate liquidity with a 3.78x current ratio and zero long-term debt, operational performance has dramatically worsened and is unsustainable without significant turnaround efforts.
CCRN Strengths
- Strong liquidity position with $108.7M cash and 3.78x current ratio
- Zero long-term debt provides financial flexibility
- Positive free cash flow of $40.1M despite operational losses
- Substantial asset base of $449M to support restructuring
CCRN Risks
- Revenue declined 21.6% YoY with operating income of -$84.4M indicating severe business headwinds
- Net margin of -9.0% and negative ROE of -29.4% show the business is destroying shareholder value
- Gross margin of only 4.6% provides minimal buffer for operational expenses and leaves no room for error
- Operating losses despite positive FCF suggest unsustainable accounting quality and potential working capital management concerns
Key Metrics to Watch
- Revenue stabilization and return to growth trajectory
- Operating margin improvement back to positive territory
- Gross margin expansion to sustainable levels above 10%
- Return on equity recovery above 5%
CCRN Financial Metrics
💡 AI Analyst Insight
The relatively thin 3.8% FCF margin may limit capital allocation flexibility. Strong liquidity with a 3.78x current ratio provides a solid financial cushion.
CCRN Profitability Ratios
CCRN vs Default Sector
How CROSS COUNTRY HEALTHCARE INC compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CCRN Balance Sheet & Liquidity
CCRN 5-Year Financial Trend
5-Year Trend Summary: CROSS COUNTRY HEALTHCARE INC's revenue has grown significantly by 20% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.05 reflects profitable operations.
CCRN Growth Metrics (YoY)
CCRN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $250.1M | $2.6M | $0.08 |
| Q2 2025 | $274.1M | -$6.7M | $-0.20 |
| Q1 2025 | $293.4M | -$490.0K | $-0.02 |
| Q3 2024 | $315.1M | $2.6M | $0.08 |
| Q2 2024 | $339.8M | -$13.4M | $-0.39 |
| Q1 2024 | $379.2M | $2.7M | $0.08 |
| Q3 2023 | $442.3M | $12.8M | $0.36 |
| Q2 2023 | $540.7M | $21.3M | $0.60 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CCRN Capital Allocation
CCRN SEC Filings
Access official SEC EDGAR filings for CROSS COUNTRY HEALTHCARE INC (CIK: 0001141103)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CCRN
What is the AI rating for CCRN?
CROSS COUNTRY HEALTHCARE INC (CCRN) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CCRN's key strengths?
Strong liquidity position with $108.7M cash and 3.78x current ratio. Zero long-term debt provides financial flexibility.
What are the risks of investing in CCRN?
Revenue declined 21.6% YoY with operating income of -$84.4M indicating severe business headwinds. Net margin of -9.0% and negative ROE of -29.4% show the business is destroying shareholder value.
What is CCRN's revenue and growth?
CROSS COUNTRY HEALTHCARE INC reported revenue of $1.1B.
Does CCRN pay dividends?
CROSS COUNTRY HEALTHCARE INC does not currently pay dividends.
Where can I find CCRN SEC filings?
Official SEC filings for CROSS COUNTRY HEALTHCARE INC (CIK: 0001141103) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CCRN's EPS?
CROSS COUNTRY HEALTHCARE INC has a diluted EPS of $-2.93.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.